MTOR and neoplasm: It is well known that deviations in the WNT-β-catenin [130], MAPK [131], JAK/STAT [132], PI3K-AKT-mTOR [133], and Transforming growth factor-β signaling pathways are the primary causes of resistance to anti-tumor immunotherapy strategy [134].